Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies .
Business Model: Non-Profit
Revenue: $540.2k
Employees: 11-50
Address:
City: Schlieren
State: Zurich
Zip:
Country: Switzerland
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.
Contact Phone:
Contact Email:
Listed Exchange:
Singapore Exchange
IPO Date:
6/13/2003
Ticker Symbol:
CYTN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2012 | Post-IPO Equity | 4 | $40M |
Abingworth Aisling Capital Amgen Ventures venBio Partners Abingworth Aisling Capital Amgen Ventures venBio Partners |
7/2000 | Series B | 7 | $32M |
Alta Partners HealthCap Novartis Aventic Partners AG New Medical Technologies Lombard Odier Global Life Science Ventures Alta Partners HealthCap Novartis Aventic Partners AG New Medical Technologies Lombard Odier |
1/2002 | Series C | $27M | 3/2005 | Post-IPO Equity | $18.6M | 1/1999 | Series A | 2 | $8M |
Novartis Global Life Science Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|